Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYGEN.L Regulatory News (YGEN)

  • There is currently no data for YGEN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Enters Offshore Arena with Global Energy Major

11 Oct 2010 07:00

RNS Number : 1413U
ViaLogy PLC
11 October 2010
 



 

ViaLogy Plc ("ViaLogy")

ViaLogy Enters Offshore Arena with Global Energy Major

Aims to demonstrate major improvements over conventional seismic analysis in deepwater and onshore

London, October 11, 2010. ViaLogy PLC (VIY) announces it has been engaged by a second global energy company for QuantumRD performance assessment projects. The analysis targets large oilfields outside the United States. Following the recent announcement of a supermajor contract, ViaLogy has been approached by several US and non-US companies for de-risking both onshore and offshore prospects.

Under the performance assessments, ViaLogy will use its proprietary quantum seismic interferometry technology, QuantumRD, to delineate productive formations in a deepwater reservoir for a large offshore development prospect. De-risking such prospects typically relies on drilling multiple, costly test wells because of the inability of conventional 3-D seismic analysis to image fluids. The offshore project requires that ViaLogy predict oil and/or gas bearing zones from 3D seismic data in a complex sandstone reservoir setting. Sandstone reservoirs are common across the globe and can be highly productive, depending upon the accuracy of mapping interlaced sediment within reservoir or basin-scale geometry to delineate source, seal and reservoir geologies. The value-add of QuantumRD is its ability to increase resolution of the seismic data to assess hydrocarbon presence and fluid saturation. The business value of being able to map subsurface saturation patterns is the potential to maximize extraction and production, and to avoid costs normally associated with locating hydrocarbons.

The client commissioning the work is a Fortune Global 500 company.

QuantumRD will also be used to determine the attributes of a major onshore formation for the client. The onshore application leverages QuantumRD's demonstrated ability to discover subtle channel sands in complex stratigraphies. ViaLogy intends to delineate and size production grade hydrocarbon-bearing depositions in an onshore reservoir that spans several hundred square miles.

These prospects have been previously analyzed by the some of the leading geophysical services providers. Both the client and the locations of the projects remain confidential.

ViaLogy has positioned QuantumRD to provide services on a global basis for a broad class of sandstone, carbonate and shale gas reservoirs to characterize formation porosity, lithology and map hydrocarbon presence. This follows two years of development and testing in onshore US prospects where QuantumRD successfully positioned multiple wells and, retrospectively, correctly explained the outcome of over 250 more wells.

ViaLogy CEO Robert W. Dean said, "These technology assessment projects are a major step forward for us, providing the opportunity to work in very large fields, showing the technology's capability offshore, and demonstrating its enormous commercial potential. In both of these offshore and onshore prospects currently available conventional seismic analysis technologies have thus far been unsuccessful."

 

For further information contact: 

ViaLogy

Terry Bond, Chairman - UK & Europe +44 (0) 1235-834734

Nominated Advisor to ViaLogy PLC (Seymour Pierce)

Mark Percy / Catherine Leftley, Corporate Finance +44 (0) 20-7107-8000

Katie Ratner / Jeremy Stephenson, Corporate Broking +44 (0) 20-7107-8000

About ViaLogy:

ViaLogy provides reservoir characterization, geophysical imaging and hydrocarbon sizing services to global oil and gas customers based on proprietary, patented active signal processing technology. ViaLogy's QuantumRD platform assists clients in de-risking prospects over a broad range of subsurface lithologies and complex stratigraphies to generate drilling targets, position offsets and enhance recovery. ViaLogy's core technology rapidly and accurately detects weak signals buried in high noise background and clutter, and is applicable to active/passive seismic, electromagnetic and magneto telluric data. By exploiting normally disregarded noise variations induced by changes in porosity, fluid presence and permeability across the formation, and adding computer-designed noise to the data, ViaLogy is able to amplify subtle noise variations to enhance areal and depth resolution in complex lithologies that are not achievable through conventional means. For more information on ViaLogy, visit www.vialogy.com.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCKMMMGDGFGGZM
Date   Source Headline
14th Dec 20217:00 amRNSHalf-year Report
6th Dec 20217:00 amRNSNotice of Half-year results
18th Nov 20217:00 amRNSDPYD screening recommended in Spain
28th Oct 20217:00 amRNSRanger® Technology to be presented at Labroots
26th Oct 20217:00 amRNSHalf-year Trading update
29th Sep 20217:00 amRNSResult of AGM
28th Sep 20213:00 pmRNSAGM update
28th Sep 20217:00 amRNSAGM Statement
15th Sep 20217:00 amRNSShare option awards
1st Sep 20217:00 amRNSISO 15189:2012 accreditation received
1st Sep 20217:00 amRNSNotice of AGM and Annual Report 2021
19th Aug 202112:04 pmRNSCOVID-19 Surge testing contract
11th Aug 20217:01 amRNSEarn-out Milestone, Issue of Equity & TVR
11th Aug 20217:00 amRNSAudited Final results&unaudited Q1 business update
6th Aug 20217:00 amRNSConfirmation of Results Date
23rd Jul 20217:00 amRNSNotice of Results
1st Jul 202111:09 amRNSHolding(s) in Company
21st Jun 20217:00 amRNSSecond Strategic Partner for Coastal Genomics
18th Jun 20217:00 amRNSContract Award: DPYD testing kits for NHS Wales
17th Jun 20214:32 pmRNSExercise of Options
9th Jun 20217:00 amRNSMulti-year licence and supply agreement
21st May 20214:30 pmRNSDirector/PDMR Shareholding
19th May 20217:00 amRNSDistribution Partnership
18th May 20217:00 amRNSLaunch of IONA Care NIPT service offering
17th May 20217:00 amRNSFurther testing service agreement for MHC
29th Apr 20217:00 amRNSFull year Trading update
26th Apr 20217:00 amRNSFurther National Microbiology Framework awards
19th Apr 20211:21 pmRNSFurther National Microbiology Framework contract
19th Apr 20217:00 amRNSNational Framework contract award
12th Apr 20217:00 amRNSEarn-out Milestone, Issue of Equity & TVR
6th Apr 20212:43 pmRNSTesting service agreement with MyHealthCheckedplc
6th Apr 20211:54 pmRNSAgreement with Boots for COVID-19 sample kits
29th Mar 20214:00 pmRNSCOVID-19 update
23rd Mar 20217:00 amRNSShare option exercises and awards
19th Mar 20217:00 amRNSTwin Pregnancy study published using IONA® Test
17th Mar 20217:00 amRNSAppointment of VP of Sales North America
11th Mar 20217:00 amRNSYourgene Genomic Services portfolio expansion
1st Mar 20217:00 amRNSFirst US Supply Agreement
22nd Feb 20217:00 amRNSPartnership with NPH
10th Feb 202110:51 amRNSCorrection: Director / PDMR Shareholding
10th Feb 20217:00 amRNSDirector/PDMR Shareholding
8th Feb 20217:00 amRNSTrading update
13th Jan 20217:00 amRNSDPYD screening recommended in Belgium
11th Jan 20217:00 amRNSClarigene® SARS-CoV-2 Product Update
8th Jan 20217:00 amRNSIssue of Share Options
24th Dec 20207:00 amRNSCOVID-19 update
17th Dec 20207:00 amRNSHalf-year Report
15th Dec 20207:00 amRNSNotice of Half-year Results
2nd Dec 20207:00 amRNSDPYD kits recommended by NHS England
2nd Dec 20207:00 amRNSGenomic testing service launch and Change of name

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.